Clinical Trials · NCT06780449
A Research Study to Look Into the Long-term Effect on Weight Loss of CagriSema in People With Obesity
- Phase
- Phase 3
- Recruitment status
- Active Not Recruiting
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 400
- Start date
- Feb 2025
- Locations
- 36 sites, 6 countries
- Primary endpoint
- Relative change in body weight